Vimarsana
Biggest News Aggregation in the World

Wockhardt Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wockhardt Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wockhardt Stock Today - Breaking & Trending Today

Wockhardt share price hits upper circuit of 5% as it raises ₹480 crore via QIP: What's happening - Vimarsana News

Wockhardt share price hits upper circuit of 5% as it raises ₹480 crore via QIP: What's happening

Wockhardt share price: Wockhardt stock was in the upper circuit of 5% at ₹555.80 on BSE and a total of 3935 shares of the firm changed hands. 

Wockhardt shares hit 52-week high, rally over 18%; here's why - Vimarsana News

Wockhardt shares hit 52-week high, rally over 18%; here's why

Wockhardt share price surged to a 52-week peak of ₹398.95 per share on the BSE on Monday.

Wockhardt Share/Stock Price Today, Live NSE/BSE - Vimarsana News

Wockhardt Share/Stock Price Today, Live NSE/BSE

Wockhardt Share/Stock Price Today: Check Wockhardt Live NSE/BSE, Historic price charts. Read Wockhardt news, profit & loss account, buy-sell, announcements, financial report, company information, annual report, balance sheet, results at Mint

Wockhardt shares jump 3% as NIH to support trial of company's antibiotic - Vimarsana News

Wockhardt shares jump 3% as NIH to support trial of company's antibiotic

The company informed that the trial will be conducted at NIAID’s Phase I clinical trial units in the USA. NIAID will sponsor the investigational new drug (IND) application for the study.